Skip to content
Boca Raton City Online – Lifestyle
Author:
Atrium Therapeutics
Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
September 21, 2026
Atrium Therapeutics to Participate in Upcoming Investor Conferences
September 2, 2026
Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 20, 2026
Atrium Therapeutics Reports Second Quarter 2026 Financial Results
August 13, 2026
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
August 13, 2026
Bronx Strangulation Defense Attorney David Mejia Colgan Explains the Difference Between Strangulation and Criminal Obstruction Charges
July 23, 2026
Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
July 20, 2026
Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome
July 14, 2026
Bronx Criminal Defense Attorney David Mejia Colgan Outlines How Domestic Violence Assault Charges Are Prosecuted Under New York Penal Law
June 26, 2026
Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 23, 2026
1
2
Next Page
→